全文获取类型
收费全文 | 24774篇 |
免费 | 1931篇 |
国内免费 | 542篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 403篇 |
妇产科学 | 58篇 |
基础医学 | 1053篇 |
口腔科学 | 21篇 |
临床医学 | 5527篇 |
内科学 | 11448篇 |
皮肤病学 | 47篇 |
神经病学 | 473篇 |
特种医学 | 822篇 |
外科学 | 1945篇 |
综合类 | 3113篇 |
预防医学 | 369篇 |
眼科学 | 28篇 |
药学 | 1503篇 |
14篇 | |
中国医学 | 304篇 |
肿瘤学 | 97篇 |
出版年
2024年 | 39篇 |
2023年 | 518篇 |
2022年 | 684篇 |
2021年 | 1104篇 |
2020年 | 1094篇 |
2019年 | 1126篇 |
2018年 | 994篇 |
2017年 | 718篇 |
2016年 | 747篇 |
2015年 | 767篇 |
2014年 | 1667篇 |
2013年 | 1545篇 |
2012年 | 1161篇 |
2011年 | 1230篇 |
2010年 | 1092篇 |
2009年 | 1074篇 |
2008年 | 1196篇 |
2007年 | 1171篇 |
2006年 | 1062篇 |
2005年 | 981篇 |
2004年 | 871篇 |
2003年 | 836篇 |
2002年 | 659篇 |
2001年 | 608篇 |
2000年 | 506篇 |
1999年 | 448篇 |
1998年 | 414篇 |
1997年 | 358篇 |
1996年 | 316篇 |
1995年 | 261篇 |
1994年 | 221篇 |
1993年 | 210篇 |
1992年 | 204篇 |
1991年 | 180篇 |
1990年 | 193篇 |
1989年 | 129篇 |
1988年 | 141篇 |
1987年 | 129篇 |
1986年 | 102篇 |
1985年 | 75篇 |
1984年 | 70篇 |
1983年 | 59篇 |
1982年 | 58篇 |
1981年 | 36篇 |
1980年 | 32篇 |
1979年 | 33篇 |
1978年 | 33篇 |
1977年 | 28篇 |
1976年 | 18篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
991.
Tips and tricks of surgical technique for pancreatic cancer: portal vein resection and reconstruction (with videos) 下载免费PDF全文
Hideyuki Yoshitomi Atsushi Kato Hiroaki Shimizu Masayuki Ohtsuka Katsunori Furukawa Tsukasa Takayashiki Satoshi Kuboki Shigetsugu Takano Daiki Okamura Daisuke Suzuki Nozomu Sakai Shingo Kagawa Masaru Miyazaki 《Journal of hepato-biliary-pancreatic sciences》2014,21(9):E69-E74
Surgical resection is the only hope for cure in patients with pancreatic cancer. To improve the resectability and achieve better prognosis of this lethal disease, extended resection for pancreatic cancer has been applied. We have performed portal vein resection aggressively for pancreatic cancer with portal vein invasion. We also established a method of portal vein reconstruction using the left renal vein graft for tumors widely extended to the portal vein. Our data show similar survival between patients with portal vein obstruction and those without invasion. We also show that portal vein reconstruction using the left renal vein graft can be performed safely without severe liver damage. With video, we introduce our surgical technique for portal vein resection and reconstruction, especially focusing on the usage of the left renal vein graft, providing several tips for a safe and successful procedure. 相似文献
992.
Introduction
Intracerebral hemorrhage (ICH) is a major clinical concern with anticoagulation therapy. The effect of a new oral direct FXa inhibitor, edoxaban, was determined in a rat model of ICH and compared with a direct thrombin inhibitor, melagatran, and heparin.Methods
To induce ICH, 0.1 U collagenase type VII was injected into the striatum of male Wistar rats under anesthesia with thiopental or halothane. Immediately after ICH induction, edoxaban, melagatran, or heparin were infused intravenously. Five hours after ICH induction, the brain was removed and ICH size was measured. To estimate the margin of safety, antithrombotic effects were evaluated in a rat venous thrombosis model.Results
Edoxaban at 6 mg/kg/h significantly increased ICH volume (1.8-fold) and prolonged prothrombin time (PT) 2.8-fold compared to the vehicle group. No deaths were observed with edoxaban. Melagatran at 1 mg/kg/h increased ICH volume at 1 mg/kg/h (2.8-fold) with 6.1-fold PT prolongation. At 3 mg/kg/h, all rats died due to severe ICH (3.9-fold). Heparin at both 100 and 500 U/kg/h significantly increased ICH. At 500 U/kg/h, 5 out of 8 rats died. The doses required for 50% inhibition of thrombosis of edoxaban, melagatran, and heparin were 0.045 mg/kg/h, 0.14 mg/kg/h, and 55 U/kg/h, respectively. The safety margins between antithrombotic and ICH exacerbation effects of these anticoagulants were 133, 7.1, and 1.8, respectively.Conclusion
The safety margin of edoxaban was wider than that of melagatran or heparin. These results suggest that edoxaban may be preferable from the perspective of ICH exacerbation risk. 相似文献993.
Peter Brønnum Nielsen Søren Lundbye-Christensen Lars Hvilsted Rasmussen Torben Bjerregaard Larsen 《Thrombosis research》2014
Introduction
Warfarin is the most widely prescribed vitamin K antagonist and in the United States and Europe more than 10 million people are currently in long-term oral anticoagulant treatment. This study aims to retrospectively validate a dynamic statistical model providing dosage suggestions to patients in warfarin treatment.Materials and methods
The model was validated on a cohort of 553 patients with a mean TTR of 83%. Patients in the cohort were self-monitoring and managed by a highly specialised anticoagulation clinic. The predictive model essentially consists of three parts handling INR history, warfarin dosage and biological noise, which allows for prediction of future INR values and optimal warfarin dose to stay on INR target. Further, the model is based on parameters initially being set to population values and gradually individualised during monitoring of patients.Primary outcome
Time in therapeutic range was used as surrogate quality measure of the treatment, and model-suggested dosage of warfarin was used to assess the accuracy of the model performance.Results
The accuracy of the model predictions measured as median absolute error was 0.53 mg/day (interquartile range from 0.25 to 1.0). The model performance was evaluated by the difference between observed and predicted warfarin intake in the preceding week of an INR measurement. In more than 70% of the cases where INR measurements were outside the therapeutic range, the model suggested a more reasonable dose than the observed intake.Conclusion
Applying the proposed dosing algorithm can potentially further increase the time in INR target range beyond 83%. 相似文献994.
Roza Chaireti Rupesh Rajani Annika Bergquist Tor Melin Inga-Lill Friis-Liby Marjo Kapraali Stergios Kechagias Tomas L. Lindahl Sven Almer 《Thrombosis research》2014
Introduction
In recent years there have been increasing evidence associating liver disease with hypercoagulability, rather than bleeding. The aim of the study was to evaluate the haemostatic potential in patients with liver disease.Patients and methods
We measured thrombin generation in the presence and absence of thrombomodulin in patients with portal vein thrombosis (PVT, n = 47), Budd-Chiari syndrome (BCS, n = 15) and cirrhosis (n = 24) and compared the results to those obtained from healthy controls (n = 21). Fifteen patients with PVT and 10 patients with BCS were treated with warfarin and were compared to an equal number of patients with atrial fibrillation matched for prothrombin time-international normalized ratio. We assessed resistance to thrombomodulin by using ratios [marker measured in the presence/absence of thrombomodulin].Results
There were no differences in thrombin generation between patients on warfarin treatment and their controls. Cirrhotic patients generated more thrombin in the presence of thrombomodulin and exhibited thrombomodulin resistance compared to controls [p = 0.006 for endogenous thrombin potential (ETP) and p < 0.001 for peak thrombin and both ratios ETP and peak] and patients with non-cirrhotic PVT (p = 0.001, p = 0.006, p < 0.001, p < 0.001 for ETP, peak, ratio ETP, ratio peak, respectively). The patients with cirrhotic PVT exhibited higher ETP (p = 0.044) and peak (p = 0.02) in the presence of thrombomodulin than controls, as well as thrombomodulin resistance (ETP and peak ratios: p = 0.001).Conclusions
Hypercoagulability and thrombomodulin resistance in patients with cirrhosis were independent of the presence of splanchnic vein thrombosis. The hypercoagulability in patients with cirrhotic PVT could have implications for considering longer or more intensive treatment with anticoagulants in this group. 相似文献995.
Introduction
The natural history of acute pulmonary embolism (PE) under treatment is about a gradual resolution of the thrombi, and uncommonly, the development of chronic thromboembolic pulmonary hypertension (CTEPH). We hypothesized that ventilatory efficiency parameters during cardiopulmonary exercise testing (CPET) may be able to monitor the process and predict CTEPH.Methods
15 patients rehabilitated from acute PE (total resolution of thrombi), 44 patients with chronic PE (with residual thrombi), 66 patients with CTEPH, and 36 sedentary healthy controls performed incremental CPET.Results
The lowest VE/VCO2 was higher in CTEPH patients than that in chronic PE and rehabilitated patients (43.4 L/min vs 29.9 L/min vs 27.1 L/min, p < 0.005). The VE/VCO2 slope (48.4 L/min/L/min vs 29.9 L/min/L/min vs 28.0 L/min/L/min, p < 0.005) and oxygen uptake efficiency plateau (OUEP) (37.1 L/min vs 27.0 L/min vs 25.2 L/min, p < 0.005) had the similar changes. In logistic regression analysis, the lowest VE/VCO2 ≥ 34.35 L/min was the best predictor of CTEPH (OR 159.0, 95% CI 36.0-702.3, p < 0.001). The lowest VE/VCO2 was higher in chronic PE patients compared with the controls (29.9 L/min vs 26.5 L/min, p < 0.05), but there was no difference between the rehabilitated patients and the controls. In multiple linear regression analysis, the percentage of vascular obstruction by ventilation-perfusion lung scanning (PVO) was the most significant independent predictor for indices of ventilatory efficiency in chronic PE and rehabilitated patients.Conclusions
CTEPH is associated with weakened ventilatory efficiency. The lowest VE/VCO2 ratio has the best capability to predict CTEPH. Ventilatory inefficiency improves along with recovery of acute PE. 相似文献996.
Mehta N Desai A Shivdasani B Suryawanshi S Mehta AB Behranwala A Dhabhar B 《Indian heart journal》2012,64(4):416-419
Primary spindle cell sarcoma of the left atrium is an extremely rare tumour. Surgical excision is the mainstay of treatment since it responds poorly to chemotherapy or radiotherapy. In spite of all the treatment, the prognosis remains poor due to inadvertent delay in diagnosis, few therapeutic options and propensity to metastasize. We present a 47-year-old male who underwent a surgical excision of a left atrial mass in February 2010. It was proved to be a high-grade spindle cell sarcoma on histopathology. He presented again in October 2010 with recurrence of the tumour for which he was re-operated. However, the tumour recurred again within one month, to which the patient succumbed. 相似文献
997.
Rajeev Bhardwaj 《Indian heart journal》2012,64(5):476-478
ObjectiveAtrial fibrillation is the commonest sustained arrhythmia. In western countries the common causes of atrial fibrillation are hypertensive heart disease, dilated cardiomyopathy, and coronary heart disease. Rheumatic heart disease being still common in India, we studied its contribution to atrial fibrillation.Material and methods137 consecutive patients of atrial fibrillation coming to our hospital were subjected to echocardiography to determine the cause.ResultsOut of 137 patients with atrial fibrillation, 76 were female (55.47%) and 61 were male (44.43%). Mean age was 51.24 ± 15.36 years. Commonest cause of AF was rheumatic heart disease found in 84 (61.31%) patients. Next common causes were hypertensive heart disease in 14 (10.2%) patients and chronic obstructive pulmonary disease (COPD) in 14 (10.2%) patients. Mean left atrial size was 47.8 ± 12.25 mm.ConclusionIn our study of patients coming from a rural back ground of North India, more than 60% patients of AF are due to RHD. Hypertensive heart disease and COPD are the next common causes. 相似文献
998.
ECG remains the first line method for detection of left ventricular hypertrophy (LVH) in patients with hypertension. ECG diagnosis of LVH predicts a several-fold increase in age- and risk factor-adjusted cardiovascular morbidity and mortality in asymptomatic patients with essential hypertension. When compared with traditional ECG methods, Cornell voltage product and multifactorial criteria such as the Perugia criterion allow detection of LVH in a higher proportion of subjects while carrying a high attributable risk for cardiovascular morbidity and mortality. Hence, traditional interpretation of standard ECG maintains an important role for cardiovascular risk stratification in hypertension. 相似文献
999.
L Fraenkel RL Street V Towle JR O'Leary L Iannone PH Van Ness TR Fried 《Journal of the American Geriatrics Society》2012,60(8):1434-1441
1000.